Enabling Technologies for Collaborative Research in Health. Ann Martin BigData2015 Munsbach, Luxembourg

Size: px
Start display at page:

Download "Enabling Technologies for Collaborative Research in Health. Ann Martin 28.10.2015 BigData2015 Munsbach, Luxembourg"

Transcription

1 Enabling Technologies for Collaborative Research in Health Ann Martin BigData2015 Munsbach, Luxembourg

2 IMI Europe s partnership for health > 5 bn 2.5 bn Partnership bn

3 IMI key concepts Focus on unmet needs Non-competitive collaborative research Competitive Calls for proposals Open collaboration in public-private consortia Data sharing, dissemination of results Industry contribution is in kind

4 IMI Knowledge Management IMI 2 Data and Knowledge Management SGG Enabling Platforms New project ideas: SGG Strategy or ad hoc proposals Research Informatics Translational Informatics Real World Data Adaptive Informatics Digital Business IMI IMI-2 RADAR Patient Hub BD4BO 4

5 Enabling Technologies & Tools Some Examples

6 etox Searchable in a database Publically available toxicology data OH HO N O N N OH Predictive in-silico models Reports from companies

7 Compound Target Pathway Disease data ü Created the Open PHACTS Discovery Platform linking information and facts from multiple public databases ü Created an API for drug discovery with an ecosystem of apps ü ü ü Methodology for delivery business-relevant solutions Use by bench and computational scientists Established itself as a a unique forum for partners ü the Open PHACTS Foundation support the existing infrastructure and widen scientific scope

8 Model Based Drug Development Clinical Trial Simulator - Prototype v.2 Adap>ve Op>mal Designs prototype V.1

9 Efforts to Automate clinical research 1 DESIGN Feasibility Study Protocol (CDISC PRM SDM) 2 EXECUTION Pa?ent Recruitment 3 EXECUTION Data Collec?on Case Report Form (CDISC ODM) FDA- EMA SUBMISSION Regulators XML XML XML Trial Registry Document Management System Clinical Trial Management System (CTMS) Clinical Data Management System (CDMS) XML

10 Ø Supports collaborative projects Ø Analysis needs of translational data Ø Deploys open-source transmart Ø Service with public data Ø Ethics / data protection Ø Standards research Ø transmart Foundation o 35 transmart implementations o multiple development teams o commercial services European Translational and Knowledge Management Services Abirisk Oncotrack UBIOPRED Predict- TB RA- MAP... studies including omics images clinical assessment data 22 transla?onal, 1400 gene expression studies J&J etriks TraIT TheHyve IDBS Sanofi Pfizer Takeda RecombinantbyDeloiPe Thomson Reuters Michigan Harvard

11 EMIF European Medical Information Framework Research topics provide focus Platform Make data available for browsing and analysis in multiple ways Alzheimers Disease Identification and validation of markers that predict Alzheimer s progression Metabolics Discovery of predictors of the metabolic complications of adult and paediatric obesity

12 Accelerated development of vaccine benefit-risk collaboration in Europe Review, develop, test methods, data sources & procedures Feed blueprint sustainable pan-european framework Deliver robust quantitative data to assess benefits & risks marketed vaccines Fast informed decisions regulators/health authorities

13 Incorporating real-life clinical data into drug development HTA assessment è value new drug for given healthcare system. need data to assess relative effectiveness guidance on generating real world data during drug development analyse existing processes and methodologies network of regulators, HTA, companies, academics, healthcare professionals, patients etc

14 Recognising Adverse Drug Reactions Mobile app: report ADRs info on meds Social media: explore identification safety signals Recommendations safety monitoring

15 ND4BB Infocentre Infocentre accross antimicrobial projects Electronic lab notebooks Transmart Code of practice secondary use medical data

16 Reinforce Data & Knowledge Management

17 General conditions for proposals Open Publications (gold or green) Data Management Plan (H2020 guidance) Adopt data standards e.g. CDISC Adapt or develop standards with SDO Dessiminate description resources using standards e.g. Dublin Core (ISO15836)

18 Results/Data dissemination Guidelines on Open Access to Scientific Publications and Research Data in Horizon 2020 Guidelines on Data Management in Horizon 2020

19 Data Management Plan template 1 page template covering Data set reference and name Data set description Standards and metadata Data sharing Archiving and preservation (including storage and back-up)

20 Data Standards & Other MOU with CDISC Extends IMI membership to beneficiaries Adopt, adapt, develop standards eg CDISC CFAST therapeutic area standards etriks starter pack Code of practice for secondary use of medical data

21 Standards facilitate regulatory submissions collaborative research in networdked R&D in & out licensing mergers & acquisitions è adoption is difficult to measure

22 Disseminate results Article 29.1 General obligation to disseminate results Make resources discoverable for metrics & re-use Describe resources using e.g. Dublin Core (ISO15836) Examples of Resources are (a collection of) biosamples, datasets, images, publications etc.

23 Under Evaluation

24 Remote Assessment of Disease and Relapse (RADAR) Caregiver Reports Literature Patents Epidemiology Predict and Preempt: Ø relapse in depression Multi-Platform Biomarker Data from Controlled Studies Physician Notes Patient Hospital Records Data Ø exacerbation in MS Ø epileptic fit Ø Onset of mania Ø Psychotic break etc. Vision of Tomorrow: Next Generation Patient Centric Data MOVE FROM DIAGNOSE AND TREAT TO PREDICT AND PREEMPT 24 Continuous Real-Time Patient Data Home Monitoring. Remote Sensing. (Actigraphy, Physiological) 24

25 Challenges in Managing Chronic Disease Today Physician visits are time-limited evaluations based on subjective observations of both the patient and the physician or psychiatrist Changes in disease state for each of these diseases can occur on timescales much shorter than the interval between physician visits Through technological advances over the last decade it is now possible to objectively, remotely, and continuously measure aspects of patient physiology, behavior and symptoms 25

26 Knowledge repository to enable patient-focus medicine Future development Pharma Pharma Pharma Knowledge Repository Patients Advocacy Groups Regulators

27 Patient input into drug development Today Pharma 1 Pharma 2 Pharma 3 Patients Advocacy Groups Regulators

28 Big Data for Better Outcomes Program

29 CSA DDN TA projects Consistency & quality policy/direc?on, objec?ves, call texts facilitate interac?ons and learnings between projects Standards for data and knowledge Implementa?on Data protection & integrity Legal & ethical standards Code of prac?ce Common ethics Board Templates/guidance Technical data security and privacy solu?ons Common minimum data standards Opera?onal interac?ons with competent authori?es Knowledge integration Policy principles (programme level) Gap analysis and recommenda?ons for projects TA specific recommenda?ons Engagement with HC stakeholders & communication Branding (templates, guidance) Programme comms material Programme website Stakeholders engagement Recommenda?ons on data formats and standards TA specific interac?ons with stakeholders (+repor?ng to CSA) Communica?on (project level) Data sustainability & growth of networks Data sustainability mechanisms (including quality of data and adequate use) Knowledge repository/ platform Processes for collec?on, use and exploita?on of knowledge and ac?ve process management Repository infrastructure Generate and manage TA specific contents IMIProgramBD4BOUpdatesv 30 July 2015.pptx 29

30 Call 6: BD4BO launched Topic 3:Real World Outcomes Across the AD Spectrum (ROADS) to Better Care Topic 4:Development of an outcomes-focused data platform to empower policy makers and clinicians to optimize care for patients with hematologic malignancies

31 Call Topics in preparation (DKM) BD4BO Coordination and Support Action European Distributed Data Network Cardiovascular Multiple Sclerosis RADAR - PAIN

32 Conclusion

33 What do we need? X1, Network of containers with services transmart / etriks Data management Data Management Plan Adopt (adapt, develop) standards CDISC, etriks starter pack Access data incl governance Code of practice

34 Thank you Ann Martin Principal Scientific Manager

The Evolution of Data Platforms in IMI. Anthony Rowe, Janssen R&D IT 08 April 2016 Med-e-Tel Luxembourg

The Evolution of Data Platforms in IMI. Anthony Rowe, Janssen R&D IT 08 April 2016 Med-e-Tel Luxembourg The Evolution of Data Platforms in IMI Anthony Rowe, Janssen R&D IT 08 April 2016 Med-e-Tel Luxembourg Three trends in technology today Ubiquity of the Internet Three trends in technology today Ubiquity

More information

TransCelerate's Role in Transforming Pharmaceutical Trials Presentation to PCORNet

TransCelerate's Role in Transforming Pharmaceutical Trials Presentation to PCORNet TransCelerate's Role in Transforming Pharmaceutical Trials Presentation to PCORNet Dalvir Gill, PhD - Chief Executive Officer 17 October, 2014 Presentation Objectives + TransCelerate History + Participating

More information

CDISC and Clinical Research Standards in the LHS

CDISC and Clinical Research Standards in the LHS CDISC and Clinical Research Standards in the LHS Learning Health System in Europe 24 September 2015, Brussels Rebecca D. Kush, PhD, President and CEO, CDISC CDISC 2015 1 CDISC Healthcare Link Goal: Optimize

More information

Transforming CliniCal Trials: The ability to aggregate and Visualize Data Efficiently to make impactful Decisions

Transforming CliniCal Trials: The ability to aggregate and Visualize Data Efficiently to make impactful Decisions : The ability to aggregate and Visualize Data Efficiently to make impactful Decisions www.eclinicalsol.com White Paper Table of Contents Maximizing Your EDC Investment... 3 Emerging Trends in Data Collection...

More information

Managing and Integrating Clinical Trial Data: A Challenge for Pharma and their CRO Partners

Managing and Integrating Clinical Trial Data: A Challenge for Pharma and their CRO Partners Managing and Integrating Clinical Trial Data: A Challenge for Pharma and their CRO Partners Within the Pharmaceutical Industry, nothing is more fundamental to business success than bringing drugs and medical

More information

Overview of the EHR4CR project Electronic Health Record systems for Clinical Research

Overview of the EHR4CR project Electronic Health Record systems for Clinical Research Overview of the EHR4CR project Electronic Health Record systems for Clinical Research Dipak Kalra UCL on behalf of the EHR4CR Consortium ENCePP Plenary Meeting, 3rd May 2012, London The problem (as addressed

More information

Building a Collaborative Informatics Platform for Translational Research: Prof. Yike Guo Department of Computing Imperial College London

Building a Collaborative Informatics Platform for Translational Research: Prof. Yike Guo Department of Computing Imperial College London Building a Collaborative Informatics Platform for Translational Research: An IMI Project Experience Prof. Yike Guo Department of Computing Imperial College London Living in the Era of BIG Big Data : Massive

More information

Accelerating Clinical Trials Through Shared Access to Patient Records

Accelerating Clinical Trials Through Shared Access to Patient Records INTERSYSTEMS WHITE PAPER Accelerating Clinical Trials Through Shared Access to Patient Records Improved Access to Clinical Data Across Hospitals and Systems Helps Pharmaceutical Companies Reduce Delays

More information

Big Data An Opportunity or a Distraction? Signal or Noise?

Big Data An Opportunity or a Distraction? Signal or Noise? Big Data An Opportunity or a Distraction? Signal or Noise? Maya R. Said, Sc.D. SVP & Global Head, Oncology Policy & Market Access, Novartis 3rd International Systems Biomedicine Symposium Luxembourg, 28

More information

Integrating pharmacological data

Integrating pharmacological data Integrating pharmacological data For scientists For software and application developers A semantic data integration infrastructure Open PHACTS is a 3-year project of the Innovative Medicines Initiative

More information

The NIH Roadmap: Re-Engineering the Clinical Research Enterprise

The NIH Roadmap: Re-Engineering the Clinical Research Enterprise NIH BACKGROUNDER National Institutes of Health The NIH Roadmap: Re-Engineering the Clinical Research Enterprise Clinical research is the linchpin of the nation s biomedical research enterprise. Before

More information

EMA and Progressive Multifocal Leukoencephalopathy.

EMA and Progressive Multifocal Leukoencephalopathy. EMA and Progressive Multifocal Leukoencephalopathy. ENCePP Plenary, London 23 November 2011 Presented by: Henry Fitt Head of Coordination & Networking, Pharmacovigilance & Risk Management An agency of

More information

The REUSE project: EHR as single datasource for biomedical research

The REUSE project: EHR as single datasource for biomedical research The REUSE project: EHR as single datasource for biomedical research Naji El Fadly 1,3, Noël Lucas 2, Pierre-Yves Lastic 4, François Macary 5, Philippe Verplancke 6, Christel Daniel 1,2 1 INSERM UMRS 872,

More information

Pa"ent Reported Outcomes Useful for Whom? Industry s Perspec/ve. Pri/ Jhingran, Ph.D. GlaxoSmithKline

Paent Reported Outcomes Useful for Whom? Industry s Perspec/ve. Pri/ Jhingran, Ph.D. GlaxoSmithKline Pa"ent Reported Outcomes Useful for Whom? Industry s Perspec/ve Pri/ Jhingran, Ph.D. GlaxoSmithKline AGENDA Why PROs? Applica0ons of PROs in Drug Development US Healthcare Reform Enhanced Value of PROs

More information

Enabling Discovery, Development, and translation of treatments for Cognitive Dysfunctions in Depression: A Workshop Session IV

Enabling Discovery, Development, and translation of treatments for Cognitive Dysfunctions in Depression: A Workshop Session IV Enabling Discovery, Development, and translation of treatments for Cognitive Dysfunctions in Depression: A Workshop Session IV Maria Isaac, MASc, MD, PhD, MFPM, Psychiatrist Senior Scientific Officer Institute

More information

THOMSON REUTERS CORTELLIS FOR INFORMATICS. REUTERS/ Aly Song

THOMSON REUTERS CORTELLIS FOR INFORMATICS. REUTERS/ Aly Song THOMSON REUTERS CORTELLIS FOR INFORMATICS REUTERS/ Aly Song THOMSON REUTERS CORTELLIS FOR INFORMATICS 1 Table of Contents Table of Contents...1 The challenge... 2 The solution... 2 WHAT CAN YOU DO WITH

More information

2nd Call for Proposals 2014 Innovative Medicines Initiative 2

2nd Call for Proposals 2014 Innovative Medicines Initiative 2 IMI2-GB-DEC-2014-XX- Annex I 2nd Call for Proposals 2014 Innovative Medicines Initiative 2 Version: SRG DRAFT All information regarding future IMI Call topics is indicative and subject to change. Final

More information

Connecting Basic Research and Healthcare Big Data

Connecting Basic Research and Healthcare Big Data Elsevier Health Analytics WHS 2015 Big Data in Health Connecting Basic Research and Healthcare Big Data Olaf Lodbrok Managing Director Elsevier Health Analytics o.lodbrok@elsevier.com t +49 89 5383 600

More information

Translational research facilitating experimental medicine in dementia in the UK

Translational research facilitating experimental medicine in dementia in the UK Translational research facilitating experimental medicine in dementia in the UK Simon Lovestone Director Biomedical Research Unit for dementia at Maudsley and King s Route Map for Dementia Research June

More information

Electronic Submission of Regulatory Information, and Creating an Electronic Platform for Enhanced Information Management

Electronic Submission of Regulatory Information, and Creating an Electronic Platform for Enhanced Information Management Written Notice of Participation by the Clinical Data Interchange Standards Consortium (CDISC) and Written Statement for Discussion Topics to be Addressed In the FDA Public Hearing: Electronic Submission

More information

Practical Image Management for

Practical Image Management for Practical Image Management for Pharma Experiences and Directions. Use of Open Source Stefan Baumann, Head of Imaging Infrastructure, Novartis Agenda Introduction Drug Development, Imaging Trial Overview

More information

Pharmacology skills for drug discovery. Why is pharmacology important?

Pharmacology skills for drug discovery. Why is pharmacology important? skills for drug discovery Why is pharmacology important?, the science underlying the interaction between chemicals and living systems, emerged as a distinct discipline allied to medicine in the mid-19th

More information

The registry of the future: Leveraging EHR and patient data to drive better outcomes

The registry of the future: Leveraging EHR and patient data to drive better outcomes The registry of the future: Leveraging EHR and patient data to drive better outcomes Brian J. Kelly, M.D. President, Payer and Provider Solutions, Quintiles Jason Colquitt, VP, IT, Head of RWLPR IT, Global

More information

CASC Fall Meeting 2014

CASC Fall Meeting 2014 CASC Fall Meeting 2014 transmart and the emergent requirement for Policies regarding Open Science and Open Data to help Sustain in Translational Research Brian D. Athey, Ph.D. Michael A. Savageau Collegiate

More information

Big Data in Health Sciences An India Prospective

Big Data in Health Sciences An India Prospective Big Data in Health Sciences An India Prospective Government Industry Dialogue 24 th Nov 2013 1 Views presented are Individual views only 2 Healthcare Ecosystem Stakeholders and Influencers Drugs and Devices

More information

HOT TOPICS IN IN HEALTH CARE REFORM

HOT TOPICS IN IN HEALTH CARE REFORM By Felicia Fuller Publications Manager, DAC Patient Recruitment Services The Patient Protection and Affordable Care Act (ACA), colloquially known as Obamacare, is in full effect and its impact is palpable

More information

An Introduction to Genomics and SAS Scientific Discovery Solutions

An Introduction to Genomics and SAS Scientific Discovery Solutions An Introduction to Genomics and SAS Scientific Discovery Solutions Dr Karen M Miller Product Manager Bioinformatics SAS EMEA 16.06.03 Copyright 2003, SAS Institute Inc. All rights reserved. 1 Overview!

More information

ELECTRONIC HEALTH RECORDS FOR CLINICAL RESEARCH

ELECTRONIC HEALTH RECORDS FOR CLINICAL RESEARCH ELECTRONIC HEALTH RECORDS FOR CLINICAL RESEARCH! BioMedBridges Annual General Meeting! Dipak Kalra, EuroRec Christian Ohmann, ECRIN Electronic Health Records for Clinical Research! on behalf of the EHR4CR

More information

MSD Information Technology Global Innovation Center. Digitization and Health Information Transparency

MSD Information Technology Global Innovation Center. Digitization and Health Information Transparency MSD Information Technology Global Innovation Center Digitization and Health Information Transparency 10 February 2014 1 We are seeking energetic, forward thinking graduates to join our Information Technology

More information

Elements for optimising Orphan drug development industry perspective

Elements for optimising Orphan drug development industry perspective Elements for optimising Orphan drug development industry perspective IRDiRC Conference, Dublin, 17 April 2013 Wills Hughes-Wilson, Vice President External Affairs, Chief Patient Access Officer, Sobi With

More information

Rationale and vision for E2E data standards: the need for a MDR

Rationale and vision for E2E data standards: the need for a MDR E2E data standards, the need for a new generation of metadata repositories Isabelle de Zegher, PAREXEL Informatics, Belgium Alan Cantrell, PAREXEL, United Kingdom Julie James, PAREXEL Informatics, United

More information

U.S. Food and Drug Administration Center for Devices and Radiological Health REGULATORY SCIENCE PRIORITIES (FY2016)

U.S. Food and Drug Administration Center for Devices and Radiological Health REGULATORY SCIENCE PRIORITIES (FY2016) U.S. Food and Drug Administration Center for Devices and Radiological Health REGULATORY SCIENCE PRIORITIES (FY2016) Executive Summary October 20, 2015 The Regulatory Science Subcommittee (RSS) of the CDRH

More information

Data Standards in Clinical Trials, A Regulatory Perspec9ve

Data Standards in Clinical Trials, A Regulatory Perspec9ve Data Standards in Clinical Trials, A Regulatory Perspec9ve NIH Data Standards Forum: Maximizing Innova8on by Standardizing Mary Ann Slack Center for Drug Evalua9on and Research (CDER) U.S. Food and Drug

More information

Bench to Bedside Clinical Decision Support:

Bench to Bedside Clinical Decision Support: Bench to Bedside Clinical Decision Support: The Role of Semantic Web Technologies in Clinical and Translational Medicine Tonya Hongsermeier, MD, MBA Corporate Manager, Clinical Knowledge Management and

More information

BRIDGing CDASH to SAS: How Harmonizing Clinical Trial and Healthcare Standards May Impact SAS Users Clinton W. Brownley, Cupertino, CA

BRIDGing CDASH to SAS: How Harmonizing Clinical Trial and Healthcare Standards May Impact SAS Users Clinton W. Brownley, Cupertino, CA BRIDGing CDASH to SAS: How Harmonizing Clinical Trial and Healthcare Standards May Impact SAS Users Clinton W. Brownley, Cupertino, CA ABSTRACT The Clinical Data Interchange Standards Consortium (CDISC),

More information

CTC Technology Readiness Levels

CTC Technology Readiness Levels CTC Technology Readiness Levels Readiness: Software Development (Adapted from CECOM s Software Technology Readiness Levels) Level 1: Basic principles observed and reported. Lowest level of software readiness.

More information

Use of Electronic Health Records in Clinical Research: Core Research Data Element Exchange Detailed Use Case April 23 rd, 2009

Use of Electronic Health Records in Clinical Research: Core Research Data Element Exchange Detailed Use Case April 23 rd, 2009 Use of Electronic Health Records in Clinical Research: Core Research Data Element Exchange Detailed Use Case April 23 rd, 2009 Table of Contents 1.0 Preface...4 2.0 Introduction and Scope...6 3.0 Use Case

More information

Analyzing NGS data with clinical data: open source software for translational medicine

Analyzing NGS data with clinical data: open source software for translational medicine Analyzing NGS data with clinical data: open source software for translational medicine BASEL LIFE SCIENCE WEEK NGS FORUM SEPTEMBER 24, 2015 Kees van Bochove, CEO The Hyve Agenda 1. Introduction 2. Open

More information

BIG DATA BREATHES LIFE INTO NEXT-GEN PHARMA R&D

BIG DATA BREATHES LIFE INTO NEXT-GEN PHARMA R&D www.wipro.com BIG DATA BREATHES LIFE INTO NEXT-GEN PHARMA R&D Dr.Sarika Vanarse Principal Consultant Pharma R&D, Industry Solutions Group Table of Contents 03... Abstract 03... Introduction 05... Preparing

More information

Healthcare Coalition on Data Protection

Healthcare Coalition on Data Protection Healthcare Coalition on Data Protection Recommendations and joint statement supporting citizens interests in the benefits of data driven healthcare in a secure environment Representing leading actors in

More information

GOVERNANCE AND THE EHR4CR INSTITUTE

GOVERNANCE AND THE EHR4CR INSTITUTE GOVERNANCE AND THE EHR4CR INSTITUTE Dipak Kalra EuroRec, University College London Christian Ohmann, European Clinical Research Infrastructure Network (ECRIN) Electronic Health Records for Clinical Research

More information

BRISTOL-MYERS SQUIBB DATA DISCLOSURE & TRANSPARENCY

BRISTOL-MYERS SQUIBB DATA DISCLOSURE & TRANSPARENCY BRISTOL-MYERS SQUIBB DATA DISCLOSURE & TRANSPARENCY TRUSTED COMPANY Since 2001, Sylogent systems have been utilized by leading BioPharma companies Publication Planning Data Disclosure & Transparency Study

More information

Data Standards and the National Cardiovascular Research Infrastructure (NCRI)

Data Standards and the National Cardiovascular Research Infrastructure (NCRI) Data Standards and the National Cardiovascular Research Infrastructure (NCRI) A partnership with Duke Clinical Research Institute (DCRI) and the American College of Cardiology Foundation (ACCF) November

More information

One Research Court, Suite 200 Rockville, MD 20850 www.ctisinc.com Tel: 301.948.3033 Fax: 301.948.2242

One Research Court, Suite 200 Rockville, MD 20850 www.ctisinc.com Tel: 301.948.3033 Fax: 301.948.2242 TRANSFORMATION OF HEALTH INDUSTRY THROUGH PERFORMANCE PYRAMID: Providing Excellent End-to-End Healthcare to the Population with a 30% Reduction in Cost and Time. Introduction The American health industry

More information

Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries

Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries April 16, 2010 Oracle is currently reviewing the existing Phase Forward product roadmap and will be

More information

Paul Vervuren Organon Copyright 2006, SAS Institute Inc. All rights reserved.

Paul Vervuren Organon Copyright 2006, SAS Institute Inc. All rights reserved. Drug Development Data Warehousing at Organon: Proof-of-concept using SAS 9 Paul Vervuren Organon Outline Context Overview DWH project Alignment DWH with operational process Concluding remarks Critical

More information

The Interface Between Biostatistics and Clinical Data Management

The Interface Between Biostatistics and Clinical Data Management The Interface Between Biostatistics and Clinical Data Management Brad H. Pollock, MPH, PhD 1 and Rick Ittenbach, PhD 2 1 Dept. of Epidemiology and Biostatistics, School of Medicine, UT Health Science Center,

More information

EMR Systems and the Conduct of Clinical Research. Daniel E Ford, MD, MPH Vice Dean for Clinical Investigation Johns Hopkins School of Medicine

EMR Systems and the Conduct of Clinical Research. Daniel E Ford, MD, MPH Vice Dean for Clinical Investigation Johns Hopkins School of Medicine EMR Systems and the Conduct of Clinical Research Daniel E Ford, MD, MPH Vice Dean for Clinical Investigation Johns Hopkins School of Medicine Clinical Research Environment Research protocols are becoming

More information

The Six A s. for Population Health Management. Suzanne Cogan, VP North American Sales, Orion Health

The Six A s. for Population Health Management. Suzanne Cogan, VP North American Sales, Orion Health The Six A s for Population Health Management Suzanne Cogan, VP North American Sales, Summary Healthcare organisations globally are investing significant resources in re-architecting their care delivery

More information

Udo Siegmann member of e3c, CDISC Sen. Dir. Acc. Management PAREXEL

Udo Siegmann member of e3c, CDISC Sen. Dir. Acc. Management PAREXEL Innovative Medicines Technological Platform Udo Siegmann member of e3c, CDISC Sen. Dir. Acc. Management PAREXEL Facts about PAREXEL Full service CRO (Clinical Research Organisation) Involved in more than

More information

Matteo di Tommaso FDA-PhUSE March 2013 Vice President, Research Business Technology Chair, PRISME Forum

Matteo di Tommaso FDA-PhUSE March 2013 Vice President, Research Business Technology Chair, PRISME Forum Pharma R&D IT & The Cloud Matteo di Tommaso FDA-PhUSE March 2013 Vice President, Research Business Technology Chair, PRISME Forum This presentation outlines a general technology direction. Pfizer Inc has

More information

Hollie Goddard Sr. IRB Coordinator McKesson Specialty Health

Hollie Goddard Sr. IRB Coordinator McKesson Specialty Health Hollie Goddard Sr. IRB Coordinator McKesson Specialty Health We are responsible for acquiring, analyzing, and protecting medical information vital to providing quality patient care HIM professionals ensure

More information

ATP Initiatives in Healthcare Informatics

ATP Initiatives in Healthcare Informatics ATP Initiatives in Healthcare Informatics Richard N. Spivack, Ph.D. Economic Assessment Office (tel.) 301-975 975-50635063 (fax) 301-975 975-4776 richard.spivack spivack@nist.gov www.atp atp.nist.gov Advanced

More information

through advances in risk-based

through advances in risk-based Insight brief Quintiles is a market leader with >100 risk-based monitoring studies Quintiles developed solutions that bring as much as 25% cost reduction over traditional trial execution approaches Transform

More information

EDITORIAL MINING FOR GOLD : CAPITALISING ON DATA TO TRANSFORM DRUG DEVELOPMENT. A Changing Industry. What Is Big Data?

EDITORIAL MINING FOR GOLD : CAPITALISING ON DATA TO TRANSFORM DRUG DEVELOPMENT. A Changing Industry. What Is Big Data? EDITORIAL : VOL 14 ISSUE 1 BSLR 3 Much has been written about the potential of data mining big data to transform drug development, reduce uncertainty, facilitate more targeted drug discovery and make more

More information

How FDA Promotes Partnerships to Accelerate Medical Product Development

How FDA Promotes Partnerships to Accelerate Medical Product Development How FDA Promotes Partnerships to Accelerate Medical Product Development ShaAvhrée Buckman-Garner, MD, PhD Director, Office of Translational Sciences Center for Drug Evaluation and Research Food and Drug

More information

Genetic Alliance BioBank: A Virtual Tour of Registry Solutions to Accelerate Research February 22, 2010

Genetic Alliance BioBank: A Virtual Tour of Registry Solutions to Accelerate Research February 22, 2010 Genetic Alliance BioBank: A Virtual Tour of Registry Solutions to Accelerate Research February 22, 2010 Liz Horn Genetic Alliance Posted in the Resource Repository at: http://www.resourcerepository.org/documents/1872/geneticalliancebiobank:avirtualto

More information

Modelling the integration of biobanks into healthcare systems International Biobanking Summit II: Future Directions Graz, 17 September 2013

Modelling the integration of biobanks into healthcare systems International Biobanking Summit II: Future Directions Graz, 17 September 2013 Modelling the integration of biobanks into healthcare systems International Biobanking Summit II: Future Directions Graz, 17 September 2013 Anthony J Brookes University of Leicester Biobank: A comprehensive

More information

What Lies Ahead? Trends to Watch: Health Care Product Development in North America

What Lies Ahead? Trends to Watch: Health Care Product Development in North America What Lies Ahead? Trends to Watch: Health Care Product Development in North America What Lies Ahead? for 2015 DIA has released its third annual What Lies Ahead? report, providing experts insights into the

More information

The Cell Therapy Catapult

The Cell Therapy Catapult The Cell Therapy Catapult Keith Thompson CEO January 29 2013 info@ct.catapult.org.uk Catapult is a Technology Strategy Board programme The Launch of Catapults Hauser 2 Hauser Report Creating new manufacturing

More information

CDISC Strategy Document Version 9 (Final BOD Approved Version) 4 December 2006

CDISC Strategy Document Version 9 (Final BOD Approved Version) 4 December 2006 CDISC Strategy Document Version 9 (Final BOD Approved Version) 4 December 2006 Introduction The Clinical Data Interchange Standards Consortium (CDISC) has established standards to support the acquisition,

More information

CLINICAL DEVELOPMENT OPTIMIZATION

CLINICAL DEVELOPMENT OPTIMIZATION PAREXEL CLINICAL RESEARCH SERVICES CLINICAL DEVELOPMENT OPTIMIZATION Enhancing the clinical development process to achieve optimal results ADVANCED TECHNOLOGY COMBINED WITH INTELLIGENT THINKING CAN HELP

More information

Shared Services and Healthcare Cloud:

Shared Services and Healthcare Cloud: Shared Services and Healthcare Cloud: A Strategy for Adoption Kristina Kermanshahche Chief Architect, Healthcare Intel Corporation April 18, 2012 Kristina.m.kermanshahche@intel.com What is Shared Services?

More information

Transla6ng from Clinical Care to Research: Integra6ng i2b2 and OpenClinica

Transla6ng from Clinical Care to Research: Integra6ng i2b2 and OpenClinica Transla6ng from Clinical Care to : Integra6ng i2b2 and OpenClinica Aaron Abend Managing Director, Recombinant Data Corp May 13, 2011 Copyright 2011 Recombinant Data Corp. All rights reserved. 1 About Recombinant

More information

Integration and Data Management In The Cloud Gary Palgon VP Healthcare Solutions GPalgon@Liaison.com

Integration and Data Management In The Cloud Gary Palgon VP Healthcare Solutions GPalgon@Liaison.com Integration and Data Management In The Cloud Gary Palgon VP Healthcare Solutions GPalgon@Liaison.com 2012 Liaison Technologies. All rights reserved. Liaison is a trademark of Liaison Technologies. What

More information

Biogen Global Medical Grants Office Multiple Sclerosis: Areas of Interest

Biogen Global Medical Grants Office Multiple Sclerosis: Areas of Interest Biogen Global Medical Grants Office Multiple Sclerosis: Areas of Interest Cycle C June 2, 2015 1 Introduction The landscape for the treatment of relapsing Multiple Sclerosis (MS) has quickly evolved over

More information

Clinical trials: The EU perspective. Dr Karim Berkouk, Deputy Head of Unit DG for Research and Innovation Health Directorate European Commission

Clinical trials: The EU perspective. Dr Karim Berkouk, Deputy Head of Unit DG for Research and Innovation Health Directorate European Commission Clinical trials: The EU perspective Dr Karim Berkouk, Deputy Head of Unit DG for Research and Innovation Health Directorate European Commission Content 1.EU: The global picture 2.EU & Clinial trials: The

More information

5 Key Trends in Connected Health

5 Key Trends in Connected Health 5 Key Trends in Connected Health One of the most exciting market opportunities in healthcare today is the near limitless set of innovative solutions that can be created through the integration of the Internet,

More information

Statistical Operations: The Other Half of Good Statistical Practice

Statistical Operations: The Other Half of Good Statistical Practice Integrating science, technology and experienced implementation Statistical Operations: The Other Half of Good Statistical Practice Alan Hopkins, Ph.D. Theravance, Inc. Presented at FDA/Industry Statistics

More information

Research Data Networks: Privacy- Preserving Sharing of Protected Health Informa>on

Research Data Networks: Privacy- Preserving Sharing of Protected Health Informa>on Research Data Networks: Privacy- Preserving Sharing of Protected Health Informa>on Lucila Ohno-Machado, MD, PhD Division of Biomedical Informatics University of California San Diego PCORI Workshop 7/2/12

More information

The Role of Regional Medical Advisor (RMA)-Field Medical. Dr. Aju Abraham Varghese Pfizer India. Feb 22 nd 2014

The Role of Regional Medical Advisor (RMA)-Field Medical. Dr. Aju Abraham Varghese Pfizer India. Feb 22 nd 2014 The Role of Regional Medical Advisor (RMA)-Field Medical Dr. Aju Abraham Varghese Pfizer India Feb 22 nd 2014 Disclaimer The opinions expressed in this presentation are solely those of the presenter and

More information

Research proposal (Part B)

Research proposal (Part B) Research and Innovation Actions (RIA) Innovation Actions (IA) Research proposal (Part B) Version 1.1 3 November 2014 Disclaimer This document is aimed at informing potential applicants for Horizon 2020

More information

Bringing Order to Your Clinical Data Making it Manageable and Meaningful

Bringing Order to Your Clinical Data Making it Manageable and Meaningful CLINICAL DATA MANAGEMENT Bringing Order to Your Clinical Data Making it Manageable and Meaningful eclinicalsol.com DATA IS SIMPLY BEAUTIFUL DATA STACKS IN STANDARD FORMATION This imaginative visual suggests

More information

Medicines and Healthcare products Regulatory Agency

Medicines and Healthcare products Regulatory Agency Medicines and Healthcare products Regulatory Agency 11 April 2016 Update on progress with the Joint Patient Safety and Vigilance Strategy Purpose: This paper provides the Board with an update on the Joint

More information

Global Alzheimer s Platform. Luc Truyen, ltruyen8@its.jnj.com George Vradenburg, vradenburg@aol.com Debra Lappin, debra.lappin@faegrebd.

Global Alzheimer s Platform. Luc Truyen, ltruyen8@its.jnj.com George Vradenburg, vradenburg@aol.com Debra Lappin, debra.lappin@faegrebd. Global Alzheimer s Platform 2015 Luc Truyen, ltruyen8@its.jnj.com George Vradenburg, vradenburg@aol.com Debra Lappin, debra.lappin@faegrebd.com 1 Presentation 1. Today s Reality 2. Global Momentum 3. GAP

More information

Avg cost of a complex trial $100mn. Avg cost per patient for a Phase III Study

Avg cost of a complex trial $100mn. Avg cost per patient for a Phase III Study 1 Industry Perspective Over the last several years, clinical research costs have sky rocketed while new drug approvals are at multi-year lows. Studies have become global in nature and more complex to manage

More information

Ahmed BEN HAMIDA,Professor

Ahmed BEN HAMIDA,Professor ICT WP 2011-12 Challenge 5 : - Objective 5.1: Personal Health Systems (PHS) Objective 5.2: Virtual Physiological Human (VPH) Objective 5.3: Patient Guidance Services (PGS) Objective 5.4: ICT for Ageing

More information

A Product and Pipeline Analysis of the Multiple Sclerosis Therapeutics Market

A Product and Pipeline Analysis of the Multiple Sclerosis Therapeutics Market A Product and Pipeline Analysis of the Multiple Sclerosis Therapeutics Market Launch of Several Pipeline Oral Products Could Diminish the Market for Injectable Therapies NEC3-52 November 2014 Contents

More information

PES Has The Sustainable Solu2on For Chronic Care Management

PES Has The Sustainable Solu2on For Chronic Care Management PES Has The Sustainable Solu2on For Chronic Care Management Empowering pa2ents to lead the management of their chronic diseases through a proven and effec2ve model of collabora2on with clinicians and caregivers.

More information

Data Management and Standardisation in Distributed Systems Biology Research

Data Management and Standardisation in Distributed Systems Biology Research Data Management and Standardisation in Distributed Systems Biology Research Martin Golebiewski Heidelberg Institute for Theoretical Studies (HITS) Heidelberg, Germany BioMedBridges workshop "Data strategies

More information

Roche Position on Human Stem Cells

Roche Position on Human Stem Cells Roche Position on Human Stem Cells Background Stem cells and treating diseases. Stem cells and their applications offer an enormous potential for the treatment and even the cure of diseases, along with

More information

ECRIN (European Clinical Research Infrastructures Network)

ECRIN (European Clinical Research Infrastructures Network) ECRIN (European Clinical Research Infrastructures Network) Wolfgang Kuchinke University of Duesseldorf (HHU) and ECRIN EUDAT 1st User Forum 7 March 2012 8 March 2012, Barcelona 1 What is ECRIN? European

More information

INSERT COMPANY LOGO HERE BEST PRACTICES RESEARCH

INSERT COMPANY LOGO HERE BEST PRACTICES RESEARCH INSERT COMPANY LOGO HERE BEST PRACTICES RESEARCH Background and Company Performance Industry Challenges esource: Electronic Clinical Trial Solution Clinical trial sponsors and clinical research organizations

More information

ECRIN IA WP4 Breakout session: structuring a European rare disesase clinical research network ECRIN Annual meeting 15-17 may 2013 Warsaw

ECRIN IA WP4 Breakout session: structuring a European rare disesase clinical research network ECRIN Annual meeting 15-17 may 2013 Warsaw ECRIN IA WP4 Breakout session: structuring a European rare disesase clinical research network ECRIN Annual meeting 15-17 may 2013 Warsaw OrphanDev s experience in supporting Clinical Trials for rare diseases

More information

Canadian National Research Data Repository Service. CC and CARL Partnership for a national platform for Research Data Management

Canadian National Research Data Repository Service. CC and CARL Partnership for a national platform for Research Data Management Research Data Management Canadian National Research Data Repository Service Progress Report, June 2016 As their digital datasets grow, researchers across all fields of inquiry are struggling to manage

More information

The right prevention and treatment for the right patient at the right time. Strategic Research Agenda for Innovative Medicines Initiative

The right prevention and treatment for the right patient at the right time. Strategic Research Agenda for Innovative Medicines Initiative The right prevention and treatment for the right patient at the right time Strategic Research Agenda for Innovative Medicines Initiative 2 Innovative Medicines Initiative IMI1 has shown the progress that

More information

Specifics of the clinical trials data life cycle (momentum for providing access to patient-level data)

Specifics of the clinical trials data life cycle (momentum for providing access to patient-level data) Specifics of the clinical trials data life cycle (momentum for providing access to patient-level data) 3rd EUDAT Conference 25 September 2014 Amsterdam, Netherlands Prof. Dr. C. Ohmann ECRIN-ERIC Major

More information

Gaining Ground in Translation Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health

Gaining Ground in Translation Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Gaining Ground in Translation Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Some Key Challenges in Biomedical Research Providing robust methods and tools for translation Conducting

More information

EHR4CR ENABLING PROACTIVE RESEARCH

EHR4CR ENABLING PROACTIVE RESEARCH EHR4CR ENABLING PROACTIVE RESEARCH Neelam Patel Neelam Consulting Electronic Health Records for Clinical Research 76 Why change how I currently operate? To more visible to the clinical trial community

More information

Big Data Analytics Driving Healthcare Transformation

Big Data Analytics Driving Healthcare Transformation Big Data Analytics Driving Healthcare Transformation Greg Caressi SVP Healthcare & Life Sciences November, 2014 Six Big Themes for the New Healthcare Economy Themes Modernizing Care Delivery Clinical practice

More information

MED 2400 MEDICAL INFORMATICS FUNDAMENTALS

MED 2400 MEDICAL INFORMATICS FUNDAMENTALS MED 2400 MEDICAL INFORMATICS FUNDAMENTALS NEW YORK CITY COLLEGE OF TECHNOLOGY The City University Of New York School of Arts and Sciences Biological Sciences Department Course title: Course code: MED 2400

More information

SAFE Digital Identity and Digital Signature Standard

SAFE Digital Identity and Digital Signature Standard SAFE Digital Identity and Digital Signature Standard Mollie Shields Uehling SAFE-BioPharma Association Company logo here The Impetus for SAFE Revolution in life sciences and medical technology: Changing

More information

School of Pharmacy TEMPLE UNIVERSITY

School of Pharmacy TEMPLE UNIVERSITY School of Pharmacy TEMPLE UNIVERSITY Regulatory Affairs and Quality Assurance Graduate Program Te mple Unive rsity School of Pharmacy Re gulatory Affairs and Quality Assurance Graduate Program 4 25 Comme

More information

Information Exchange and Data Transformation (INFORMED) Initiative

Information Exchange and Data Transformation (INFORMED) Initiative Information Exchange and Data Transformation (INFORMED) Initiative Sean Khozin, MD, MPH Senior Medical Officer Office of Hematology and Oncology Products (OHOP) Food and Drug Administration (FDA) The opinions

More information

Telling the Data Story: Use of Informatics, Harmonized Semantics and Metadata in the National Children s Study

Telling the Data Story: Use of Informatics, Harmonized Semantics and Metadata in the National Children s Study Telling the Data Story: Use of Informatics, Harmonized Semantics and Metadata in the National Children s Study John Lumpkin, MS, MBA, PMP Steven Hirschfeld, MD, PhD NIH-NICHD-National Children s Study

More information

My Big Data experience getting my feet wet in the puddle and still treading water 2 years later 28 th June 2013. Rob Walls Healthcare Data Analytics

My Big Data experience getting my feet wet in the puddle and still treading water 2 years later 28 th June 2013. Rob Walls Healthcare Data Analytics My Big Data experience getting my feet wet in the puddle and still treading water 2 years later 28 th June 2013 Rob Walls Healthcare Data Analytics Abstract "Big Data" - Electronic Health Records (EHR)

More information

ehealth ELSA: The perspective of the VPH research community

ehealth ELSA: The perspective of the VPH research community ehealth ELSA: The perspective of the VPH research community Bernard de Bono, Peter Coveney, Alejandro Frangi, Martin Hofmann-Apitius, Rod Hose, Marco Viceconti VPH Network of Excellence ELSA Meeting Brussels,

More information

How To Change Medicine

How To Change Medicine P4 Medicine: Personalized, Predictive, Preventive, Participatory A Change of View that Changes Everything Leroy E. Hood Institute for Systems Biology David J. Galas Battelle Memorial Institute Version

More information

Big Data in Healthcare: Current Possibilities and Emerging Opportunities

Big Data in Healthcare: Current Possibilities and Emerging Opportunities Big Data in Healthcare: Current Possibilities and Emerging Opportunities Andrew Bate Senior Director, Epidemiology Group Lead, Analytics 23 th March 2015 The Long Road In Developing a New Medicine Clinical

More information

TRANSFORMING LIFE SCIENCES THROUGH ENTERPRISE ANALYTICS

TRANSFORMING LIFE SCIENCES THROUGH ENTERPRISE ANALYTICS TRANSFORMING LIFE SCIENCES THROUGH ENTERPRISE HOW SOLUTIONS AND ENTERPRISE ENVIRONMENTS ARE IMPROVING EFFICIENCY AND ENABLING NEW INSIGHTS THROUGHOUT THE LIFE SCIENCES INDUSTRY Matt Gross Director Health

More information